45 results on '"biotherapeutics"'
Search Results
2. Antimicrobial therapeutic protein extraction from fruit waste and recent trends in their utilization against infections
3. Exploring the Multifaceted Therapeutic Potential of Probiotics: A Review of Current Insights and Applications
4. Immunogenicity of Atezolizumab: Influence of Testing Method and Sampling Frequency on Reported Anti-drug Antibody Incidence Rates
5. Secretome from iPSC-derived MSCs exerts proangiogenic and immunosuppressive effects to alleviate radiation-induced vascular endothelial cell damage
6. EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening
7. The NMR signature of maltose-based glycation in full-length proteins
8. Human Dose and Pharmacokinetic Predictions for Biologics at Boehringer Ingelheim: A Retrospective Analysis
9. Human secretory and excretory fluids, molecular constituents, and their biotherapeutic perspective against fungal pathogen Candida albicans
10. Development of human-machine language interfaces for the visual analysis of complex biologics and RNA modalities and associated experimental data
11. Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
12. Fundamental concepts of protein therapeutics and spacing in oncology: an updated comprehensive review
13. Mechanistic Modeling of the Effect of Recombinant Human Hyaluronidase (rHuPH20) on Subcutaneous Delivery of Cetuximab in Rats
14. Determination of Anti-drug Antibody Affinity in Clinical Study Samples Provides a Tool for Evaluation of Immune Response Maturation
15. Application of blood microsampling in cynomolgus monkey and demonstration of equivalent monoclonal antibody PK parameters compared to conventional sampling
16. Unexplored Excipients in Biotherapeutic Formulations: Natural Osmolytes as Potential Stabilizers Against Thermally Induced Aggregation of IgG1 Biotherapeutics
17. Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective
18. Application of Genetic Engineering in Biotherapeutics Development
19. Local Treatment of Non-small Cell Lung Cancer with a Spray-Dried Bevacizumab Formulation
20. Selective suppression of excipient signals in 2D 1H–13C methyl spectra of biopharmaceutical products
21. Lymphatic Distribution of Etanercept Following Intravenous and Subcutaneous Delivery to Rats
22. Mapping the Binding Interface of VEGF and a Monoclonal Antibody Fab-1 Fragment with Fast Photochemical Oxidation of Proteins (FPOP) and Mass Spectrometry
23. Developing anti-neoplastic biotherapeutics against eIF4F
24. Differentiating biosimilarity and comparability in biotherapeutics
25. Beta-glucan contamination of pharmaceutical products: How much should we accept?
26. Recent Advances in Application of Pharmacogenomics for Biotherapeutics
27. Balanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer
28. Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
29. Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents
30. In Silico Evaluation of the Potential Impact of Bioanalytical Bias Difference between Two Therapeutic Protein Formulations for Pharmacokinetic Assessment in a Biocomparability Study
31. Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics
32. Perspectives on Using Nanoscale Delivery Systems in Dermatological Treatment
33. Rhinovirus and Asthma: a Storied History of Incompatibility
34. Computationally driven deletion of broadly distributed T cell epitopes in a biotherapeutic candidate
35. Evaluation of Acoustic Membrane Microparticle (AMMP) Technology for a Sensitive Ligand Binding Assay to Support Pharmacokinetic Determinations of a Biotherapeutic
36. Comparison of Succinimidyl [125I]Iodobenzoate with Iodogen Iodination Methods to Study Pharmacokinetics and ADME of Biotherapeutics
37. High-throughput analysis of therapeutic and diagnostic monoclonal antibodies by multicapillary SDS gel electrophoresis in conjunction with covalent fluorescent labeling
38. Protein Particulate Detection Issues in Biotherapeutics Development—Current Status
39. Disulfide Scrambling in IgG2 Monoclonal Antibodies: Insights from Molecular Dynamics Simulations
40. Coupling of Aggregation and Immunogenicity in Biotherapeutics: T- and B-Cell Immune Epitopes May Contain Aggregation-Prone Regions
41. Potential Aggregation-Prone Regions in Complementarity-Determining Regions of Antibodies and Their Contribution Towards Antigen Recognition: A Computational Analysis
42. Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy
43. Varying polymer architecture to deliver drugs
44. A Randomized Trial of Yogurt for Prevention of Antibiotic-Associated Diarrhea
45. Liposomes and biotherapeutics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.